Ordinary Adjustment | Solactive Global Genomics Immunology and Medical Revolution Index | Effective Date 1st June 2026

May 19, 2026

Announcement

Ordinary Adjustment | Solactive Global Genomics Immunology and Medical Revolution Index | Effective Date 1st June 2026

Solactive Global Genomics Immunology and Medical Revolution Index:

In the ordinary adjustment, the following composition will be implemented effective open 1st June 2026:

10X GENOMICS INC
ABBVIE INC
ADAPTIVE BIOTECHNOLOGIES CORP
ARROWHEAD PHARMACEUTICALS INC
ASCENTAGE PHARMA GROUP INTERNATIONAL
AXSOME THERAPEUTICS INC
BEONE MEDICINES LTD
BILLIONTOONE INC.
BIOGEN INC
BIONTECH SE
BRIDGEBIO PHARMA INC
BRISTOL-MYERS SQUIBB CO
CARIS LIFE SCIENCES INC
CELLTRION INC
CRISPR THERAPEUTICS AG
ELI LILLY & CO
GENEDX HOLDINGS CORP
GENMAB A/S
GENSCRIPT BIOTECH CORP
GILEAD SCIENCES INC
GUARDANT HEALTH INC
HUTCHMED CHINA LTD
ILLUMINA INC
IMMUNITYBIO INC
INNOCARE PHARMA LTD
INTELLIA THERAPEUTICS INC
IOVANCE BIOTHERAPEUTICS INC
JOHNSON & JOHNSON
LEGEND BIOTECH CORP
MERCK & CO. INC.
MODERNA INC
NATERA INC
Nuvalent Inc
PFIZER INC
PRECIGEN INC
Praxis Precision Medicines Inc
QIAGEN NV
RECURSION PHARMACEUTICALS INC
REGENERON PHARMACEUTICALS
REVVITY INC
SAMSUNG BIOLOGICS CO LTD
SANOFI SA
SAREPTA THERAPEUTICS INC
SCHOLAR ROCK HOLDING CORP
SUMMIT THERAPEUTICS PLC
TELIX PHARMACEUTICALS LTD
TEVA PHARMACEUTICAL IND LTD
TWIST BIOSCIENCE CORP
VERTEX PHARMACEUTICALS INC
VIKING THERAPEUTICS INC

Share your view and thoughts

We work closely with our internal partners to deliver investment ideas that generate demonstrable value for our clients.